CI Cigna Group (CI) Q3 FY25 earnings call
The Cigna Group reported robust Q3 FY25 results, driven by strong performance in Cigna Healthcare and Evernorth's Specialty and Care Services. The company is proactively transforming its Pharmacy Benefit Services with a new rebate-free model and strategic client renewals, which will lead to near-term margin pressure but is expected to ensure long-term durability. Management reaffirmed its full-year EPS outlook, signaling confidence in its diverse portfolio and strategic initiatives.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
CI operating KPIs by quarter
| KPI | Mar 2025 Q1 FY25 | This call Sep 2025 Q3 FY25 | Mar 2026 Q1 FY26 | Jun 2026 Q2 FY26 | Change vs prior quarter |
|---|---|---|---|---|---|
| Medical care ratio Cigna Healthcare | 82.2%The medical care ratio for the first quarter was 82.2%.Source: earnings call transcript | 84.8%Our overall Cigna Healthcare segment-wide medical care ratio was 84.8% for the quarter, driven by an updated view of risk adjustment in our individual exchange business.Source: earnings call transcript | 79.8%The medical care ratio for the first quarter was 79.8%.Source: earnings call transcript | 84.5%The medical care ratio for the second quarter was 84.5%, slightly ahead of expectations.Source: earnings call transcript | +4.7 pt |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.